Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proto Labs (PRLB) Inventory (2016 - 2025)

Proto Labs (PRLB) has disclosed Inventory for 15 consecutive years, with $14.4 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 17.03% to $14.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.4 million through Dec 2025, up 17.03% year-over-year, with the annual reading at $14.4 million for FY2025, 17.03% up from the prior year.
  • Inventory hit $14.4 million in Q4 2025 for Proto Labs, up from $14.1 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $15.1 million in Q2 2022 to a low of $9.1 million in Q2 2021.
  • Historically, Inventory has averaged $13.0 million across 5 years, with a median of $13.4 million in 2022.
  • Biggest five-year swings in Inventory: decreased 17.26% in 2021 and later surged 65.2% in 2022.
  • Year by year, Inventory stood at $13.2 million in 2021, then rose by 3.17% to $13.6 million in 2022, then increased by 0.58% to $13.7 million in 2023, then decreased by 9.9% to $12.3 million in 2024, then rose by 17.03% to $14.4 million in 2025.
  • Business Quant data shows Inventory for PRLB at $14.4 million in Q4 2025, $14.1 million in Q3 2025, and $13.2 million in Q2 2025.